Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

First-in-human trial of AX-0810 will evaluate safety, tolerability, pharmacokinetics, and target engagement in healthy volunteers with initial data expected in Q4 2025Marks the first submitted Clinica ...

SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...

The US National Institutes of Health (NIH) has not yet rescinded directives that led to the cancellation of more than 2,400 ...

Florida Cancer Specialists & Research Institute, LLC (FCS) has been awarded two grants by the Florida Cancer Innovation Fund. The grants, Scaling Remote Temperature Monitoring in Community Oncology: ...

Manchester’s inward investment agency MIDAS has launched a new life sciences prospectus showcasing the city-region's strength in the sector. Business leaders also hailed ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

ORLANDO, FLORIDA / ACCESS Newswire / June 27, 2025 / RedChip Companies will air an interview with Greenwich LifeSciences, Inc ...

Mesothelioma is a rare malignancy affecting people exposed to asbestos. Each year, across all cancer diagnoses, mesothelioma accounts for fewer than 3,000 cases. As a result, research interest in this ...

Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), ...